Conmed (CNMD) Tops Q2 EPS by 88c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $47.09 -1.24%
EPS Growth %: -7.4%
Financial Fact:
Interest expense: 3.86M
Today's EPS Names:
OMID, SICP, SCKT, More
EPS Growth %: -7.4%
Financial Fact:
Interest expense: 3.86M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q2 EPS of ($0.07), $0.88 better than the analyst estimate of ($0.95). Revenue for the quarter came in at $157.8 million versus the consensus estimate of $126.59 million.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Baldwin Group posts 31% revenue gain, reports pending go-private deal
- West Coast Community Bancorp (WCCB) Tops Q3 EPS by 15c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
